The abnormal recovery cycle of somatosensory evoked potential components in children with migraine can be reversed by topiramate

Cephalalgia

Volumn 30, Issue 1, 2010, Pages 17-26

  Vollono, C ^a   Ferraro, D ^a   Miliucci, R ^a   Vigevano, F ^a   Valeriani, M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Children; Migraine; Pain; Recovery cycle; Somatosensory evoked potentials

Indexed keywords

TOPIRAMATE;

ADOLESCENT; AMPLITUDE MODULATION; ARTICLE; CHILD; CLINICAL ARTICLE; CONVALESCENCE; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROSTIMULATION; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HEADACHE; HUMAN; LATENT PERIOD; MALE; MIGRAINE; MIGRAINE AURA; NEUROPHYSIOLOGY; SCHOOL CHILD;

ADOLESCENT; ANTICONVULSANTS; CHILD; ELECTRIC STIMULATION; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; FRUCTOSE; HUMANS; MALE; MIGRAINE WITHOUT AURA; REACTION TIME; SOMATOSENSORY CORTEX;

EID: 77956260980     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01892.x     Document Type: Article

References (42)

1. Schoenen J, Ambrosini A, Sándor PS, Maertens de Noordhout A. Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol 2003;114:955-72.
2. Ambrosini A, Schoenen J. The electrophysiology of migraine. Curr Opin Neurol 2003;16:327-31.
3. Welch KM. Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention. Headache 2005;45(Suppl. 1):S25-32.
4. Stankewitz A, May A. Cortical excitability and migraine. Cephalalgia 2007;27:1454-6.
5. Schoenen J. Neurophysiological features of the migrainous brain. Neurol Sci 2006;27(Suppl. 2):S77-81.
6. Sandor PS. Migraine excitability. Cephalalgia 2007;27:1440-1.
7. Coppola G, Pierelli F, Schoenen J. Is the cerebral cortex hyperexcitable or hyperresponsive in migraine? Cephalalgia 2007;27:1427-39.
8. Valeriani M, Fierro B, Brighina F. Brain excitability in migraine: hyperexcitability or inhibited inhibition? Pain 2007;132:219-20.
9. Torquati K, Franciotti R, Della Penna S, Babiloni C, Rossini PM, Romani GL, Pizzella V. Conditioning transcutaneous electrical nerve stimulation induces delayed gating effects on cortical response: a magnetoencephalographic study. Neuroimage 2007;35:1578-85.
10. Ugawa Y, Genba K, Shimpo T, Mannen T. Somatosensory evoked potential recovery (SEP-R) in myoclonic patients. Electroencephalogr Clin Neurophysiol 1991;80:21-5.
11. Ugawa Y, Genba-Shimizu K, Kanazawa I. Somatosensory evoked potential recovery (SEP-R) in various neurological disorders. Electroencephalogr Clin Neurophysiol 1996;100:62-7.
12. Frasson E, Priori A, Bertolasi L, Mauguière F, Fiaschi A, Tinazzi M. Somatosensory disinhibition in dystonia. Mov Disord 2001;16:674-82.
13. Valeriani M, Rinalduzzi S, Vigevano F. Multilevel somatosensory system disinhibition in children with migraine. Pain 2005;118:137-44.
14. Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, et al. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 2005;45:1304-12.
15. Lakshmi CV, Singhi P, Malhi P, Ray M. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol 2007;22:829-35.
16. Vollono C, Ferraro D, Valeriani M. Antiepileptic drugs in the preventive treatment of migraine in children and adolescents. Drug Development Res 2007;68:1-5.
17. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000;41(Suppl. 1):S3-9.
18. Akerman S, Goadsby PJ. Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. NeuroReport 2005;16:1383-7.
19. Ramadan NM, Buchanan TM. New and future migraine therapy. Pharmacol Ther 2006;112:199-212.
20. de Tommaso M, Marinazzo D, Nitti D, Pellicoro M, Guido M, Serpino C, Stramaglia S. Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine. Clin Neurophysiol 2007;118:2297-304.
21. Aurora SK, Barrodale P, Chronicle EP, Mulleners WM. Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness. Headache 2005;45:546-52.
22. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004;24(Suppl. 1):9-160.
23. Restuccia D, Mauguière F. The contribution of median nerve SEPs in the functional assessment of the cervical spinal cord in syringomyelia. A study of 24 patients. Brain 1991;114:361-79.
24. Restuccia D, Di Lazzaro V, Valeriani M, Conti G, Tonali P, Mauguiere F. Origin and distribution of P13 and P14 far-field potentials after median nerve stimulation. Scalp, nasopharyngeal and neck recording in healthy subjects and in patients with cervical and cervico-medullary lesions. Electroencephalogr Clin Neurophysiol 1995;96:371-84.
25. Reis J, Tergau F, Hamer HM, Muller HH, Knake S, Fritsch B, et al. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia 2002;43:1149-56.
26. Inghilleri M, Conte A, Frasca V, Curra' A, Gilio F, Manfredi M, Berardelli A. Antiepileptic drugs and cortical excitability: a study with repetitive transcranial stimulation. Exp Brain Res 2004;154:488-93.
27. Inghilleri M, Gilio F, Conte A, Frasca V, Marini Bettolo C, Iacovelli E, et al. Topiramate and cortical excitability in humans: a study with repetitive transcranial magnetic stimulation. Exp Brain Res 2006;174:667-72.
28. + current fractions by the new anticonvulsant topiramate. J Pharmacol Exp Ther 1999;288:960-8.
29. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006;59:652-61.
30. Leao A, Morison R. Propagation of spreading cortical depression. J Neurophysiol 1945;8:33-45.
31. Ambrosini A, Schoenen J. Electrophysiological response patterns of primary sensory cortices in migraine. J Headache Pain 2006;7:377-88.
32. Ziemann U, Rothwell JC, Ridding MC. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol 1996;496:873-81.
33. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, et al. Corticocortical inhibition in human motor cortex. J Physiol 1993;471:501-19.
34. Hoshiyama M, Kakigi R. New concept for the recovery function of short-latency somatosensory evoked cortical potentials following median nerve stimulation. Clin Neurophysiol 2002;113:535-41.
35. de Vries B, Freilinger T, Vanmolkot KR, Koenderink JB, Stam AH, Terwindt GM, et al. Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. Neurology 2007;69:2170-6.
36. Ambrosini A, De Pasqua V, Afra J, Sandor PS, Schoenen J. Reduced gating of middle-latency auditory evoked potentials (P50) in migraine patients: another indication of abnormal sensory processing? Neurosci Lett 2001;306:132-4.
37. Ozkul Y, Uckardes A. Median nerve somatosensory evoked potentials in migraine. Eur J Neurol 2002;9:227-32.
38. Lang E, Kaltenhauser M, Neundorfer B, Seidler S. Hyperexcitability of the primary somatosensory cortex in migraine-a magnetoencephalographic study. Brain 2004;127:2459-69.
39. Knezevic-Pogancev M. Epidemiology, characteristics and distinctiveness of headaches in children from Vojvodina, Serbia. Neuroepidemiology 2008;31:122-8.
40. de Tommaso M. Central nervous system excitability in migraine: who is right? Pain 2005;118:1-2.
41. Bohotin V, Fumal A, Van den heede M, Gérard P, Bohotin C, Maertens de Noordhout A, Schoenen J. Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine. Brain 2002;125:912-22.
42. Brighina F, Giglia G, Scalia S, Francolini M, Palermo A, Fierro B. Facilitatory effects of 1 Hz rTMS in motor cortex of patients affected by migraine with aura. Exp Brain Res 2005;161:34-8.